Literature DB >> 16630991

Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.

Hajime Iwama1, Shiro Uemura, Noriyuki Naya, Kei-ichi Imagawa, Yasuhiro Takemoto, Osamu Asai, Kenji Onoue, Satoshi Okayama, Satoshi Somekawa, Yoshitomi Kida, Yukiji Takeda, Kimihiko Nakatani, Minoru Takaoka, Hiroyuki Kawata, Manabu Horii, Tamio Nakajima, Naofumi Doi, Yoshihiko Saito.   

Abstract

OBJECTIVES: Our aim was to investigate cardiac expression of placental growth factor (PlGF) and its clinical significance in patients with acute myocardial infarction (AMI).
BACKGROUND: Placental growth factor is known to stimulate wound healing by activating mononuclear cells and inducing angiogenesis. The clinical significance of PlGF in AMI is not yet known.
METHODS: Fifty-five AMI patients and 43 control subjects participated in the study. Peripheral blood sampling was performed on days 1, 3, and 7 after AMI. Blood was also sampled from the coronary artery (CAos) and the coronary sinus (CS), before and after acute coronary recanalization. Cardiac expression of PlGF was analyzed in a mouse AMI model.
RESULTS: In AMI patients, peripheral plasma PlGF levels on day 3 were significantly higher than in control subjects. Plasma PlGF levels just after recanalization were significantly higher in the CS than the CAos, which indicates cardiac production and release of PlGF. Peripheral plasma levels of PlGF on day 3 were negatively correlated with the acute phase left ventricular ejection fraction (LVEF), positively correlated with both acute phase peak peripheral monocyte counts and chronic phase changes in LVEF. Placental growth factor messenger ribonucleic acid expression was 26.6-fold greater in a mouse AMI model than in sham-operated mice, and PlGF was expressed mainly in endothelial cells within the infarct region.
CONCLUSIONS: Placental growth factor is rapidly produced in infarct myocardium, especially by endothelial cells during the acute phase of myocardial infarction. Placental growth factor might be over-expressed to compensate the acute ischemic damage, and appears to then act to improve LVEF during the chronic phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630991     DOI: 10.1016/j.jacc.2005.11.064

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  25 in total

1.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kosha Ruparel; Nancy K Sweitzer; James C Fang; Wayne C Levy; Douglas B Sawyer; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

2.  Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.

Authors:  An H Bui; Marc P Bonaca; Marc S Sabatine; Kausik K Ray; Nader Rifai; Christopher P Cannon; David A Morrow
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

3.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

4.  Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.

Authors:  Muhammad Hammadah; Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Malory Weber; Xi Wang; Michael A Samara; Yuping Wu; Javed Butler; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

5.  Fluid shear stress upregulates placental growth factor in the vessel wall via NADPH oxidase 4.

Authors:  Nabil A Rashdan; Pamela G Lloyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-25       Impact factor: 4.733

Review 6.  Vascular endothelial growth factor in heart failure.

Authors:  Ziad Taimeh; John Loughran; Emma J Birks; Roberto Bolli
Journal:  Nat Rev Cardiol       Date:  2013-07-16       Impact factor: 32.419

Review 7.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 8.  Placental growth factor as a protective paracrine effector in the heart.

Authors:  Federica Accornero; Jeffery D Molkentin
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

9.  Potential role for plasma placental growth factor in predicting coronary heart disease risk in women.

Authors:  Aedín Cassidy; Stephanie E Chiuve; JoAnn E Manson; Kathyrn M Rexrode; Cynthia J Girman; Eric B Rimm
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-16       Impact factor: 8.311

10.  Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes.

Authors:  Ronald J Torry; Robert J Tomanek; Wei Zheng; Steven J Miller; Carlos A Labarrere; Donald S Torry
Journal:  J Heart Lung Transplant       Date:  2009-02       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.